Identification of genomic biomarkers of disease progression and survival in primary CNS lymphoma
Abstract: The determination of the genetic subtypes of primary central nervous system lymphoma (PCNSL) and their relationship to differential chemoimmunotherapeutic response has not been established. There is a particular need for genomic biomarkers that identify patients with newly diagnosed PCNSL...
| Auteurs principaux: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Langue: | English |
| Publié: |
Elsevier
2025-03-01
|
| Collection: | Blood Advances |
| Accès en ligne: | http://www.sciencedirect.com/science/article/pii/S2473952924006530 |